Search

everythinglearnresearchcommunity

for

Search:↓

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

The postnatal thymus has cells like mesenchymal stem cells that can become different cell types and help maintain thymus structure.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

People with Down syndrome often have skin issues and need regular check-ups for early treatment.

Careful management of blood thinners is crucial for lupus patients with APS.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

CD99 is highly present in certain skin cells and could help treat skin conditions.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.